The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content
Joseph H. Saunders
| Saunders and Walker

Th FDA wants to meet with the manufacturers of bile duct stents regarding their “off label” use for surgical applications. The stents are the latest drug or medical device to draw the attention of the FDA for inappropriate, or at least, unapproved use. The unapproved or off label uses comes as a direct result of the companies’ overly aggressive marketing tactics.

Comments are closed.